Key points are not available for this paper at this time.
Peritoneal dialysis (PD) has become a well-established alternative to hemodialysis (HD) as the first-line renal replacement modality. During the COVID-19 pandemic, we generated a renal replacement therapy program with PD as the first option in acute and chronic patients. Patients admitted to urgent-onset PD continued ambulatory treatment
JIMENEZ et al. (Mon,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: